Page last updated: 2024-10-30

mesalamine and Constriction, Pathologic

mesalamine has been researched along with Constriction, Pathologic in 8 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Constriction, Pathologic: The condition of an anatomical structure's being constricted beyond normal dimensions.

Research Excerpts

ExcerptRelevanceReference
"Endoscopic postoperative recurrences occur early after 'curative' surgery for Crohn's disease."2.68Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). ( Belaiche, J; Cortot, A; Daurat, M; Dupas, JL; Faucheron, JL; Florent, C; Gendre, JP; Jacquet, N; Lerebours, E; Malafosse, M; Michot, F; Modigliani, R; Quandale, P; Rothman, N; Sahmound, T; Sarfaty, E; Soulé, JC; Valleur, P, 1996)
"Cumulative incidences of recurrence were estimated with a Bayesian multivariable proportional hazards model."1.72Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West. ( Arkenbosch, JHC; Beelen, EMJ; Bodelier, AGL; de Boer, NKH; de Vries, AC; Dijkstra, G; Erler, NS; Ho, JCL; Hoentjen, F; Mak, JWY; Ng, SC; Romberg-Camps, M; Stassen, LPS; van der Meulen, AE; van der Woude, CJ; van Ruler, O; West, R, 2022)
"Up to 3."1.48Crohn's Disease Behavior and Location is Altered when Associated with Primary Sclerosing Cholangitis. ( Dotan, I; Iny, O; Maharshak, N; Matalon, S; Santo, E; Shibolet, O; Yanai, H, 2018)
"In both Crohn's disease and ulcerative colitis patients in deep remission, the incidence rate of relapse was 19% per patient-year."1.46Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study. ( Aicart, M; Alcaín, G; Almela, P; Arguelles-Arias, F; Arias-Rivera, ML; Barreiro-de Acosta, M; Barrio, J; Beltrán, B; Benítez, JM; Bermejo, F; Botella, B; Bujanda, L; Busquets, D; Calvet, X; Casanova, MJ; Castaño-Milla, C; Castro, E; Castro, L; Ceballos, D; Chaparro, M; Cortés, X; Domènech, E; Domínguez, M; Domínguez-Antonaya, M; Dueñas, C; Esteve, M; Fernández-Salazar, L; García-Herola, A; García-López, S; García-Planella, E; García-Sánchez, V; García-Sepulcre, MF; Garrido, E; Gisbert, JP; Gómez-García, M; Gomollón, F; González-Lama, Y; Guardiola, J; Gutiérrez, A; Hernández-Martínez, A; Hervías, D; Hinojosa, J; Huguet, JM; Jauregui-Amezaga, A; Khorrami, S; Leo, E; Llaó, J; Lorente-Poyatos, R; Mañosa, M; Marín-Jiménez, I; Marrero, JM; Martín-Arranz, M; Martinez-Montiel, MP; Menacho, M; Merino, O; Monfort, D; Moraleja, I; Muñoz, C; Muñoz, F; Nantes, O; Navarro-Llavat, M; Novella, MT; Opio, V; Pajares, R; Pérez-Calle, JL; Pérez-Martínez, I; Pineda, JR; Ponferrada, A; Ramírez-de la Piscina, P; Ramos, L; Robles-Alonso, V; Rodríguez, C; Rodríguez, GE; Rodríguez-Pérez, A; Rojas-Feria, M; Roncedo, O; Sánchez-Torres, A; Sicilia, B; Taxonera, C; Tosca, J; Van Domselaar, M; Vázquez, JM; Vega-López, AB, 2017)
"Gastroduodenal Crohn disease is a complex and difficult problem that is associated with serious complications and need for reoperation."1.30An audit of gastroduodenal Crohn disease: clinicopathologic features and management. ( Allan, RN; Keighley, MR; Yamamoto, T, 1999)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's0 (0.00)29.6817
2010's4 (50.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Arkenbosch, JHC1
Mak, JWY1
Ho, JCL1
Beelen, EMJ1
Erler, NS1
Hoentjen, F1
Bodelier, AGL1
Dijkstra, G1
Romberg-Camps, M1
de Boer, NKH1
Stassen, LPS1
van der Meulen, AE1
West, R1
van Ruler, O1
van der Woude, CJ1
Ng, SC1
de Vries, AC1
Flum, DR1
Read, TE1
Iny, O1
Yanai, H1
Matalon, S1
Santo, E1
Shibolet, O1
Dotan, I1
Maharshak, N1
Vegh, Z1
Burisch, J1
Pedersen, N1
Kaimakliotis, I1
Duricova, D1
Bortlik, M1
Avnstrøm, S1
Vinding, KK1
Olsen, J1
Nielsen, KR1
Katsanos, KH1
Tsianos, EV1
Lakatos, L1
Schwartz, D1
Odes, S1
Lupinacci, G1
De Padova, A1
Jonaitis, L1
Kupcinskas, L1
Turcan, S1
Tighineanu, O1
Mihu, I1
Barros, LF1
Magro, F1
Lazar, D1
Goldis, A1
Fernandez, A1
Hernandez, V1
Niewiadomski, O1
Bell, S1
Langholz, E1
Munkholm, P1
Lakatos, PL1
Casanova, MJ1
Chaparro, M1
García-Sánchez, V1
Nantes, O1
Leo, E1
Rojas-Feria, M1
Jauregui-Amezaga, A1
García-López, S1
Huguet, JM1
Arguelles-Arias, F1
Aicart, M1
Marín-Jiménez, I1
Gómez-García, M1
Muñoz, F1
Esteve, M1
Bujanda, L1
Cortés, X1
Tosca, J1
Pineda, JR1
Mañosa, M1
Llaó, J1
Guardiola, J1
Pérez-Martínez, I1
Muñoz, C2
González-Lama, Y1
Hinojosa, J1
Vázquez, JM1
Martinez-Montiel, MP1
Rodríguez, GE1
Pajares, R1
García-Sepulcre, MF1
Hernández-Martínez, A1
Pérez-Calle, JL1
Beltrán, B1
Busquets, D1
Ramos, L1
Bermejo, F1
Barrio, J1
Barreiro-de Acosta, M1
Roncedo, O1
Calvet, X1
Hervías, D1
Gomollón, F1
Domínguez-Antonaya, M1
Alcaín, G1
Sicilia, B1
Dueñas, C1
Gutiérrez, A1
Lorente-Poyatos, R1
Domínguez, M1
Khorrami, S1
Taxonera, C1
Rodríguez-Pérez, A1
Ponferrada, A1
Van Domselaar, M1
Arias-Rivera, ML1
Merino, O1
Castro, E1
Marrero, JM1
Martín-Arranz, M1
Botella, B1
Fernández-Salazar, L1
Monfort, D1
Opio, V1
García-Herola, A1
Menacho, M1
Ramírez-de la Piscina, P1
Ceballos, D1
Almela, P1
Navarro-Llavat, M1
Robles-Alonso, V1
Vega-López, AB1
Moraleja, I1
Novella, MT1
Castaño-Milla, C1
Sánchez-Torres, A1
Benítez, JM1
Rodríguez, C1
Castro, L1
Garrido, E1
Domènech, E1
García-Planella, E1
Gisbert, JP1
Pilgrim, S1
Velchuru, V1
Waters, G1
Tsiamis, A1
Lal, R1
Florent, C1
Cortot, A1
Quandale, P1
Sahmound, T1
Modigliani, R1
Sarfaty, E1
Valleur, P1
Dupas, JL1
Daurat, M1
Faucheron, JL1
Lerebours, E1
Michot, F1
Belaiche, J1
Jacquet, N1
Soulé, JC1
Rothman, N1
Gendre, JP1
Malafosse, M1
Yamamoto, T1
Allan, RN1
Keighley, MR1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
"Prospective and Multicenter Study About the Epidemiology and the Characteristics Omics in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain"[NCT03689257]376 participants (Actual)Observational2017-10-01Completed
Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: Multicentre, Prospective, Randomized Clinical Trial and Economic Evaluation[NCT02994836]Phase 4139 participants (Actual)Interventional2017-04-21Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for mesalamine and Constriction, Pathologic

ArticleYear
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID).
    European journal of gastroenterology & hepatology, 1996, Volume: 8, Issue:3

    Topics: Administration, Oral; Adolescent; Adult; Aged; Aminosalicylic Acids; Anastomosis, Surgical; Anti-Inf

1996

Other Studies

7 other studies available for mesalamine and Constriction, Pathologic

ArticleYear
Indications, Postoperative Management, and Long-term Prognosis of Crohn's Disease After Ileocecal Resection: A Multicenter Study Comparing the East and West.
    Inflammatory bowel diseases, 2022, 06-02, Volume: 28, Issue:Suppl 2

    Topics: Bayes Theorem; Constriction, Pathologic; Crohn Disease; Humans; Ileum; Mesalamine; Prognosis; Recurr

2022
Evidence-Based Management of Diverticular Disease: What's New and What's Missing?
    Diseases of the colon and rectum, 2020, Volume: 63, Issue:6

    Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clinical Decision-Making; Colorectal

2020
Crohn's Disease Behavior and Location is Altered when Associated with Primary Sclerosing Cholangitis.
    The Israel Medical Association journal : IMAJ, 2018, Volume: 20, Issue:1

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Case-Control Studies; Cholangitis, Sclerosing; Colon

2018
Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
    Journal of Crohn's & colitis, 2014, Volume: 8, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Australia; Coho

2014
Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.
    The American journal of gastroenterology, 2017, Volume: 112, Issue:1

    Topics: Adalimumab; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antirheumatic Agents; Colitis,

2017
Diaphragm disease and small bowel enteropathy due to nonsteroidal anti-inflammatory drugs: a surgical perspective.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2011, Volume: 13, Issue:4

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Constriction, Pathologic; Diaphragm; Diclofe

2011
An audit of gastroduodenal Crohn disease: clinicopathologic features and management.
    Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:10

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Child; Constriction, Pathologic; C

1999